BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for AC Immune S.A.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:36 pm Purchase | 2024-09-30 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 19,522,436 19.700% | 4,951,200 (+33.98%) | Filing |
| 2023-12-19 4:53 pm Purchase | 2023-12-15 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 14,571,236 14.800% | 7,142,857 (+96.16%) | Filing |
| 2023-02-13 5:53 pm Purchase | 2022-12-31 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,428,379 8.900% | 366,000 (+5.18%) | Filing |
| 2022-02-14 1:41 pm Sale | 2021-12-31 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,062,379 9.700% | -854,279 (-10.79%) | Filing |
| 2021-01-14 4:48 pm Sale | 2021-01-12 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,916,658 11.000% | -3,425,847 (-30.20%) | Filing |